 |
FDA Approval Activities for this Drug
Diabinese (chlorpropamide) Tablets, USP, Pfizer NDA 11-641/S-058 & 11-641/S-060 CHLORPROPAMIDE Tablet; 100MG CHLORPROPAMIDE Geneva | 088726 CHLORPROPAMIDE Tablet; 250MG CHLORPROPAMIDE Geneva | 088548 CHLORPROPAMIDE Tablet; 100MG CHLORPROPAMIDE Mylan
| 088549 CHLORPROPAMIDE Tablet; 250MG CHLORPROPAMIDE Mylan
| 088175 CHLORPROPAMIDE Tablet; 100MG CHLORPROPAMIDE Par 088176 CHLORPROPAMIDE Tablet; 250MG CHLORPROPAMIDE Par 011641 CHLORPROPAMIDE Tablet; 100MG DIABINESE PFIZER
| 011641 CHLORPROPAMIDE Tablet; 250MG DIABINESE PFIZER
| 088921 CHLORPROPAMIDE Tablet; 100MG CHLORPROPAMIDE Pliva
| 088922 CHLORPROPAMIDE Tablet; 250MG CHLORPROPAMIDE Pliva
| 088694 CHLORPROPAMIDE Tablet; 100MG CHLORPROPAMIDE SUPERPHARM
| 088852 CHLORPROPAMIDE Tablet; 100MG CHLORPROPAMIDE Watson 088826 CHLORPROPAMIDE Tablet; 250MG CHLORPROPAMIDE Watson Diabinese (chlorpropamide) Tablets, USP, Pfizer Inc. | Diabinese (chlorpropamide) Tablets, Pharmacia & Upjohn Co., Packaging Addition | Diabinese (chlorpropamide) Tablets, Pfizer, Inc., Labeling Revision
^ FDA's latest approval appears at the bottom of this list. ^
|